VCU Massey Cancer Center


A Legacy of Innovation: Over 20 Years of Research Advances at VCU Massey Cancer Center

register to attend

Thursday, September 5, 2019

Omni Hotel Richmond
James River Ballroom
100 S. 12th St., Richmond, VA 23219

Please join Dr. Marsha Rappley, CEO of the VCU Health System, in honoring Dr. Gordon Ginder and his two-plus decades of leadership at VCU Massey Cancer Center. This research symposium will feature presentations highlighting the scientific achievements made at Massey under Dr. Ginder’s tenure as well as new directions for the future of cancer research. Seating is limited. Register early to attend.

For event questions, please contact:
Farah Mirza, MBA
(804) 628-1750

Symposium program

(subject to change)

8:30–9:00 Breakfast

Welcome remarks
Michael Rao, Ph.D., president of VCU and VCU Health System
Marsha D. Rappley, M.D., CEO of VCU Health System and vice president of VCU Health Sciences

9:15–9:35 Massey’s research achievements in the last 20+ years
Steven Grossman, M.D., Ph.D., deputy director of Massey Cancer Center and chair of Hematology, Oncology and Palliative Care
9:35–9:40 Video tribute to Dr. Ginder
9:40–12:10 Morning sessions: Hematologic cancers
9:40–9:50 Personal reflections on Dr. Ginder and speaker introduction
Richard Moran, Ph.D., retired Massey researcher and leader
9:50–10:20 Presentation of Massey science
Steven Grant, M.D., associate director for translational research and program co-leader of Developmental Therapeutics at Massey
10:20–10:30 Personal reflections on Dr. Ginder and speaker introduction
John McCarty, M.D., director of Cellular Immunotherapies and Transplant at Massey
10:30–11:00 Presentation of Massey science
Amir Toor, M.D., member of the Developmental Therapeutics program at Massey
11:00–11:10 Personal reflections on Dr. Ginder and speaker introduction
Linda Burns, M.D., medical director of the National Marrow Donor Program
11:10–12:10  Keynote presentation
Timothy Ley, M.D., professor in the Department of Medicine, Oncology Division, Section of Stem Cell Biology at Washington University School of Medicine and research member at Siteman Cancer Center 
12:10–1:00 Lunch
1:00–3:45 Afternoon sessions: Breast cancer
1:00–1:10 Personal reflections on Dr. Ginder and speaker introduction
Charles Geyer, M.D., associate director for clinical research at Massey
1:10–2:10 Keynote presentation
Harold Burstein, M.D., Ph.D., member of the breast cancer program at Dana-Farber Cancer Institute, associate professor of medicine at Harvard Medical School and staff physician at Brigham And Women’s Hospital
2:10–2:20 Personal reflections on Dr. Ginder and speaker introduction
Charles Clevenger, M.D., Ph.D., member of the Cancer Cell Signaling program at Massey and chair of Pathology
2:20–2:50 Presentation of Massey science
Harry Bear, M.D., Ph.D., member of the Developmental Therapeutics program at Massey and chair of Surgical Oncology
2:50–3:00 Personal reflections on Dr. Ginder and speaker introduction
John Roberts, M.D., former Massey researcher and leader, medical director of the Yale New Haven Health Adult Sickle Cell Program and professor of internal medicine at Yale Medicine
3:00–3:30 Presentation of Massey science
Douglas Arthur, M.D., associate director for clinical affairs at Massey and chair of Radiation Oncology
3:30–3:45 Closing remarks


About Dr. Gordon Ginder

Gordon D. Ginder, M.D., has served as director of VCU Massey Cancer Center since 1997. After 22 years as one of the longest-standing National Cancer Institute-designated Cancer Center directors, he has announced his desire to step down as Massey’s director when a successor is in place, for which a national search is underway. He will remain at Massey as a scientist, where his lab focuses on regulating genes that are critical to immune cells killing cancer cells, as a physician specialized in treating blood and lymph node cancers, and as a professor at the VCU School of Medicine. He will continue contributing to research, teaching and patient care.

Dr. Ginder leaves a lasting legacy that has impacted countless lives within and beyond our community. Under his leadership, Massey has taken on and maintained a trajectory of carefully planned steady growth, substantially building its scientific base and output fueled by a fourfold increase in extramural, philanthropic and state funding for life-saving cancer research. Reflecting these outstanding achievements, he successfully led five highly competitive renewals for Massey’s NCI designation. During his tenure, critical, state-of-the-art spaces for cancer research, training and care were developed across the university and health system, including the addition of Goodwin Research Laboratory, the first building at VCU dedicated solely to cancer research. He also oversaw the development of a strong research program in cancer prevention and control and strengthened multidisciplinary cancer care.

In 2003, Dr. Ginder was honored by the Governor and by the Science Museum of Virginia as Virginia’s Outstanding Scientist of the Year, and in 2015 he was bestowed the University Award of Excellence at VCU.